Statistics for A robust two-stage design identifying the optimal biological dose for phase I/II clinical trials
Total visits
| views | |
|---|---|
| A robust two-stage design identifying the optimal biological dose for phase I/II clinical trials | 257 |
Total visits per month
| views | |
|---|---|
| April 2024 | 0 |
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
File Visits
| views | |
|---|---|
| nihms808998.pdf | 296 |
Top country views
| views | |
|---|---|
| United States | 205 |
| Russia | 8 |
| Germany | 7 |
| Ukraine | 6 |
| Canada | 2 |
| United Kingdom | 2 |
| Vietnam | 2 |
| China | 1 |
| Cyprus | 1 |
| Italy | 1 |
| Malaysia | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 59 |
| Fairfield | 25 |
| Ann Arbor | 23 |
| Cambridge | 15 |
| Washington | 12 |
| Houston | 11 |
| Jacksonville | 7 |
| Kiev | 6 |
| Kiez | 6 |
| Moscow | 3 |
| Overland Park | 3 |
| Saint Petersburg | 3 |
| San Francisco | 3 |
| Chicago | 2 |
| Concord | 2 |
| Dong Ket | 2 |
| Lake Mary | 2 |
| Toronto | 2 |
| Abingdon | 1 |
| Beijing | 1 |
| Brooklyn | 1 |
| Gunzenhausen | 1 |
| Indianapolis | 1 |
| Lemesos | 1 |
| Milan | 1 |
| New York | 1 |
| Philadelphia | 1 |
| Scottsdale | 1 |
| Seattle | 1 |
| Seremban | 1 |
| Togliatti | 1 |
| Tula | 1 |
| West Chester | 1 |